Prices of 21 New Drugs fixed by NPPA; Details Meghna A Singhania4 April 2019 10:00 AM ISTThe NPPA order is likely to affect drug majors including Torrent Pharma, Alkem Laboratories, Zydus Pharmaceuticals, Cadila Healthcare, Mylan, Cipla,...
Dr Reddy's launches Tadalafil Tablets to treat erectile dysfunction Farhat Nasim28 March 2019 12:06 PM ISTDr Reddy's Tadalafil tablets are available in four strengths including 2.5 mg, 5 mg, 10 mg, and 20 mg, each in 30-count bottle size.New Delhi: Dr...
Dr Reddys launches B2B Customer Service Portal XCEED Garima19 March 2019 10:00 AM ISTDr Reddys launch of XCEED gives now instant access to an industry-leading portfolio which spans across a wide range of indications and complex...
USFDA completes audit for Dr Reddys Shreveport plant, no observations issued Medical Dialogues Bureau23 Feb 2019 9:30 AM IST"The audit of our formulations Shreveport plant, Louisiana, USA, by the United States Food and Drug Administration (USFDA) has been completed with...
Dr Reddys recalls 2770 bags of Levetiracetam Sodium Chloride injection in US market Farhat Nasim22 Feb 2019 11:53 AM ISTAs per the latest Enforcement Report of the US Food and Drug Administration (USFDA), Dr Reddys is recalling Levetiracetam in 0.54 per cent Sodium...
Dr Reddys launches Tadalafil tablets for treating erectile dysfunction Farhat Nasim13 Feb 2019 12:31 PM ISTNew Delhi: Hyderabad based drug major, Dr Reddy's has recently launched Tadalafil tablets in the US market. The drug launched is used to treat...
Brilinta War: AstraZeneca, Dr Reddys in patent battle over generic version of ticagrelor Ruby Khatun Khatun27 July 2018 3:31 PM ISTNew Delhi: Dr Reddy's Laboratories has been dragged to Delhi High Court by AstraZeneca in order to block the firm from launching the generic versions...
Dr Reddy's Lab shares gain 3 percent on zero USFDA observations for Srikakulam plant Ruby Khatun Khatun5 Jun 2018 10:30 AM ISTNew Delhi: Shares of Dr Reddys Laboratories rose by nearly 3 percent after the company said the USFDA has completed its API Srikakulam plant audit...
DRL recalls 80,000 plus bottles of Atorvastatin from US due to quality concerns Medical Dialogues Bureau9 Feb 2018 11:28 AM ISTHYDERABAD: Dr. Reddy's Laboratories has initiated a voluntary recall of over 80,000 bottles of its drug Atorvastatin Calcium Tablets 10mg, 20mg and...
Dr Reddy's gets EIR for Hyderabad facility Ruby Khatun Khatun4 Dec 2017 10:45 AM ISTNew Delhi: Drug firm Dr. Reddy's Laboratories today said it has received establishment inspection report (EIR) from the US health regulator for its...
Dr Reddy's gets nod to restart exports to EU from Vizag plant Ruby Khatun Khatun2 Dec 2017 10:30 AM ISTNew Delhi: Dr. Reddy's Laboratories said a German regulatory authority has allowed company's Visakhapatnam-based plant to restart production for the...
Securities class action lawsuit served on Dr Reddys in US Ruby Khatun Khatun1 Dec 2017 10:41 AM ISTNew Delhi: Drug firm Dr. Reddy's Laboratories on Wednesday said it has been served a securities class action lawsuit in the US for alleged violations...
